Clinical Research Directory
Browse clinical research sites, groups, and studies.
Breath Analysis for the Detection of Invasive Fungal Infections
Sponsor: University of Zurich
Summary
Patients with leukemia and concomitant neutropenia are at high risk of developing invasive fungal infections (IFI) that are associated with high morbidity and mortality. As these patients typically have severe thrombocytopenia, direct diagnostic sampling with invasive procedures is often not possible due to the high peri-interventional risk. Therefore, the presumptive diagnosis of IFI is primarily based on compatible lung findings on computed tomography and serologic detection of fungal cell wall components, which, however, have limited sensitivity and specificity. With the present study, the investigators aim to determine a set of specific volatile biomarkers in leukemia patients with proven or probable IFI using secondary electrospray ionization high-resolution mass spectrometry (SESI-HRMS).
Official title: Real-time Breath Analysis for the Detection of Invasive Fungal Infections in Neutropenic High-risk Patients
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
130
Start Date
2024-08-19
Completion Date
2027-10-31
Last Updated
2025-04-10
Healthy Volunteers
No
Conditions
Interventions
Secondary electrospray ionization high-resolution mass spectrometry (SESI-HRMS)
Identify volatile biomarkers of IFI by analyzing the breath metabolome of patients with proven or probable IFI according to the criteria outlined by EORTC/MSG and controls.
Locations (1)
University Hospital of Zurich
Zurich, Canton of Zurich, Switzerland